発表した論文の一覧です。タイトルをクリックするとPubMedで詳細を見ることができます。
- Fanconi Anemia Complementation Group E (FANCE), a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma
Junichi Takahashi, Takaaki Masuda, Akihiro Kitagawa, Taro Tobo, Yusuke Nakano, Tadashi Abe, Yuki Ando, Keisuke Kosai, Yuta Kobayashi, Yoshihiro Matsumoto, Tomoharu Yoshizumi, Masaki Mori, Koshi Mimori
Oncology. 2021 Nov 1. doi: 10.1159/000520582. Online ahead of print.PMID: 34724663
- Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy
Takaaki Masuda, Osamu Niizeki, Takashi Niizeki, Kenji Fujiyoshi, Yuki Ando, Hiroshi Niizeki, Koshi Mimori
Case Rep Oncol. 2021 Sep 3;14(3):1261-1265. doi: 10.1159/000517854. eCollection Sep-Dec 2021.PMID: 34720925
- GET4 is a novel driver gene in CRC that regulates the localization of BAG6, a nucleo-cytoplasmic shuttling protein
Kensuke Koike, Takaaki Masuda, Kuniaki Sato, Atsushi Fujii, Hiroaki Wakiyama, Taro Tobo, Junichi Takahashi, Yushi Motomura, Takafumi Nakano, Hideyuki Saito, Yoshihiro Matsumoto, Hajime Otsu, Kazuki Takeishi, Yusuke Yonemura, Koshi Mimori, Takashi Nakagawa
Cancer Sci. 2021 Oct 26. doi: 10.1111/cas.15174. Online ahead of print.PMID: 34704338
- Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer
Qingjiang Hu, Takaaki Masuda, Kensuke Koike, Kuniaki Sato, Taro Tobo, Shotaro Kuramitsu, Akihiro Kitagawa, Atsushi Fujii, Miwa Noda, Yusuke Tsuruda, Hajime Otsu, Yosuke Kuroda, Shuhei Ito, Eiji Oki, Koshi Mimori
Sci Rep. 2021 Sep 28;11(1):19178. doi: 10.1038/s41598-021-98485-9.PMID: 34584127
- Clinical usefulness of a novel fluorescence technique for the intraoperative diagnosis of surgical margins in patients with breast cancer
Ueo H, Ueo H, Minoura I, Gamachi A, Doi T, Yamaguchi M, Yamashita T, Tsuda H, Moriya T, Yamaguchi R, Kozuka Y, Sasaki T, Masuda T, Kai Y, Kubota Y, Urano Y, Mori M, Mimori K.
Br J Surg. 2021 Aug 24:znab265. doi: 10.1093/bjs/znab265. Online ahead of print.PMID: 34428279
- The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy
Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S, Ishigami K, Mimori K.
Cancer Res.2021 Aug 19:canres.0653.2021. doi: 10.1158/0008-5472.CAN-21-0653. Online ahead of print.PMID: 34413060
- Cancer-associated Fibroblast-derived Spondin-2 Promotes Motility of Gastric Cancer Cells
Shotaro Kuramitsu, Takaaki Masuda, Qingjiang Hu, Taro Tobo, Masakazu Yashiro, Atsushi Fujii, Akihiro Kitagawa, Tadashi Abe, Hajime Otsu, Shuhei Ito, Eiji Oki, Masaki Mori, Koshi Mimori
Cancer Genomics Proteomics. Jul-Aug 2021;18(4):521-529. doi: 10.21873/cgp.20277.PMID: 34183385
- Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer.
Yuta Kobayashi, Takaaki Masuda, Atsushi Fujii, Dai Shimizu, Kuniaki Sato, Akihiro Kitagawa, Taro Tobo, Yuki Ozato, Hideyuki Saito, Shotaro Kuramitsu, Miwa Noda, Hajime Otsu, Tsunekazu Mizushima, Yuichiro Doki, Hidetoshi Eguchi, Masaki Mori, Koshi Mimori
Cancer Sci. 2021 May 18. doi: 10.1111/cas.14969. Online ahead of print.PMID: 34008277
- Postoperative elevation in the plasma CCL2 level is a predictive biomarker of colorectal cancer recurrence.
Mitsuko Fukunaga, Koshi Mimori, Takaaki Masuda, Qingjiang Hu, Kazutaka Yamada, Masaki Mori
Surg Today. 2021 Apr 2. doi: 10.1007/s00595-021-02273-x. Online ahead of print.PMID: 33797637
- Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Qingjiang Hu, Kentaro Nonaka, Hiroaki Wakiyama, Yu Miyashita, Yoshiaki Fujimoto, Tomoko Jogo, Kentaro Hokonohara, Ryota Nakanishi, Yuichi Hisamatsu, Koji Ando, Yasue Kimura, Takaaki Masuda, Eiji Oki, Koshi Mimori, Yoshinao Oda, Masaki Mori
Cancer Med. 2021 Mar 26. doi: 10.1002/cam4.3828. Online ahead of print.PMID: 33769705
- The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Fujii A, Masuda T, Iwata M, Tobo T, Wakiyama H, Koike K, Kosai K, Nakano T, Kuramitsu S, Kitagawa A, Sato K, Kouyama Y, Shimizu D, Matsumoto Y, Utsunomiya T, Ohtsuka T, Yamanishi Y, Nakamura M, Mimori K.
Cancer Sci. 2021 Feb 19. doi: 10.1111/cas.14858. Online ahead of print.PMID: 33605496
- Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases.
Sakimura S, Nagayama S, Fukunaga M, Hu Q, Kitagawa A, Kobayashi Y, Hasegawa T, Noda M, Kouyama Y, Shimizu D, Saito T, Niida A, Tsuruda Y, Otsu H, Matsumoto Y, Uchida H, Masuda T, Sugimachi K, Sasaki S, Yamada K, Takahashi K, Innan H, Suzuki Y, Nakamura H, Totoki Y, Mizuno S, Ohshima M, Shibata T, Mimori K
PLoS Genet. 2021 Jan 21;17(1):e1009113. doi: 10.1371/journal.pgen.1009113. eCollection 2021 Jan.
PMID: 33476333
- Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K.
PLoS One. 2020 Oct 23;15(10):e0241140. doi: 10.1371/journal.pone.0241140. eCollection 2020.
PMID: 33095806 - A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T-cell immunotherapy in advanced breast cancer.
Masuda T, Nonami A, Tanaka F, Ando Y, Eto M, Mimori K.
Breast J. 2020 Dec;26(12):2420-2423. doi: 10.1111/tbj.14108. Epub 2020 Dec 5.
PMID: 33277749 - Genetic landscape of external auditory canal squamous cell carcinoma.
Sato K, Komune N, Hongo T, Koike K, Niida A, Uchi R, Noda T, Kogo R, Matsumoto N, Yamamoto H, Masuda M, Oda Y, Mimori K, Nakagawa T.
Cancer Sci. 2020 Aug;111(8):3010-3019. doi: 10.1111/cas.14515. Epub 2020 Jul 11.
PMID: 32500594 - The Expression Level of PD-L1 ( CD274) mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer
Masuda T, Noda M, Kitagawa A, Hu Q, Fujii A, Ito S, Kosai K, Ando Y, Matsumoto Y, Ohtsu H, Uchida H, Ohno S, Mimori K.
Anticancer Res. 2020 Jul;40(7):3733-3742. doi: 10.21873/anticanres.14362.
PMID: 32620612 - Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer
Ito S, Masuda T, Noda M, Hu Q, Shimizu D, Kuroda Y, Eguchi H, Tobo T, Utsunomiya T, Mimori K.
Oncology. 2020;98(7):501-511. doi: 10.1159/000506075.
PMID: 32380498 - SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma
Kidogami S, Iguchi T, Sato K, Yoshikawa Y, Hu Q, Nambara S, Komatsu H, Ueda M, Kuroda Y, Masuda T, Mori M, Doki Y, Mimori K.
Anticancer Res. 2020 May;40(5):2941-2946. doi: 10.21873/anticanres.14272.
PMID:32366446 - Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients.
Noda M, Masuda T, Ito S, Tobo T, Kitagawa A, Hu Q, Shimizu D, Eguchi H, Etoh T, Ohno S, Inomata M, Mimori K.
Ann Surg Oncol. 2020 Mar 21. doi: 10.1245/s10434-020-08375-z. Online ahead of print.
PMID:32206951 - KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma.
Kitagawa A, Masuda T, Takahashi J, Tobo T, Noda M, Kuroda Y, Hu Q, Kouyama Y, Kobayashi Y, Kuramitsu S, Sato K, Fujii A, Yoshikawa Y, Wakiyama H, Shimizu D, Tsuruda Y, Eguchi H, Doki Y, Mori M, Mimori K.
Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):141-149. doi: 10.21873/cgp.20174.
PMID:32108036 - Drug repositioning in cancer: The current situation in Japan.
Masuda T, Tsuruda Y, Matsumoto Y, Uchida H, Nakayama KI, Mimori K.
Cancer Sci. 2020 Jan 19. doi: 10.1111/cas.14318. [Epub ahead of print] Review.
PMID: 31957175 - N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study.
Masuda T, Ueo H, Kai Y, Noda M, Hu Q, Sato K, Fujii A, Hayashi N, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Ohno S, Mimori K, Ueo H.
Int J Mol Sci. 2020 Jan 14;21(2). pii: E511. doi: 10.3390/ijms21020511.
PMID: 31947504 - Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer.
Masuda T, Noda M, Kogawa T, Kitagawa D, Hayashi N, Jomori T, Nakanishi Y, Nakayama KI, Ohno S, Mimori K.
Cancer Sci. 2020 Mar;111(3):924-931. doi: 10.1111/cas.14306. Epub 2020 Feb 11.
PMID: 31943636 - GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.
Nambara S, Masuda T, Kobayashi Y, Sato K, Tobo T, Koike K, Noda M, Ogawa Y, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Mimori K.
Cancer Sci. 2020 Feb;111(2):343-355. doi: 10.1111/cas.14248. Epub 2019 Dec 27.
PMID: 31758608
- 【検診データの適正な解釈と患者指導】データの解釈と指導の実際 腫瘍マーカー
北川 彰洋(九州大学病院別府病院 外科), 小林 雄太, 野田 美和, 清水 大, 三森 功士
臨牀と研究 (0021-4965)96巻8号 Page941-945(2019.08)
解説/特集 - Distinct methylation levels of mature microRNAs in gastrointestinal cancers.
Konno M, Koseki J, Asai A, Yamagata A, Shimamura T, Motooka D, Okuzaki D, Kawamoto K, Mizushima T, Eguchi H, Takiguchi S, Satoh T, Mimori K, Ochiya T, Doki Y, Ofusa K, Mori M, Ishii H.
Nat Commun. 2019 Aug 29;10(1):3888. doi: 10.1038/s41467-019-11826-1.
PMID:31467274 - miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.
Mukohyama J, Isobe T, Hu Q, Hayashi T, Watanabe T, Maeda M, Yanagi H, Qian X, Yamashita K, Minami H, Mimori K, Sahoo D, Kakeji Y, Suzuki A, Dalerba P, Shimono Y.
Cancer Res. 2019 Aug 15. doi: 10.1158/0008-5472.CAN-18-3544. [Epub ahead of print]
PMID: 31416845 - Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
Kouyama Y, Masuda T, Fujii A, Ogawa Y, Sato K, Tobo T, Wakiyama H, Yoshikawa Y, Noda M, Tsuruda Y, Kuroda Y, Eguchi H, Ishida F, Kudo SE, Mimori K.
Cancer Sci. 2019 Oct;110(10):3132-3144. doi: 10.1111/cas.14163. Epub 2019 Aug 29.
PMID: 31390121 - Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer.
Sato K, Masuda T, Hu Q, Tobo T, Gillaspie S, Niida A, Thornton M, Kuroda Y, Eguchi H, Nakagawa T, Asano K, Mimori K.
EBioMedicine. 2019 Jun;44:387-402. doi: 10.1016/j.ebiom.2019.05.058. Epub 2019 Jun 4.
PMID: 31175057 - Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents.
Yumimoto K, Sugiyama S, Mimori K, Nakayama KI.
Cancer Sci. 2019 Jul;110(7):2090-2099. doi: 10.1111/cas.14075. Epub 2019 Jun 10. Review.
PMID: 31111571 - Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.
Muto Y, Moroishi T, Ichihara K, Nishiyama M, Shimizu H, Eguchi H, Moriya K, Koike K, Mimori K, Mori M, Katayama Y, Nakayama KI.
J Exp Med. 2019 Apr 1;216(4):950-965. doi: 10.1084/jem.20180900. Epub 2019 Mar 15.
PMID: 30877170 - A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.
Hayashi N, Kuroda Y, Saito T, Tsuruda Y, Niida A, Otsu H, Eguchi H, Masuda T, Suzuki Y, Natsugoe S, Mimori K.
Surg Today. 2019 Sep;49(9):738-747. doi: 10.1007/s00595-019-01789-7. Epub 2019 Mar 6.
PMID: 30843125 - Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.
Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.
Cancer Sci. 2019 Apr;110(4):1464-1479. doi: 10.1111/cas.13968. Epub 2019 Mar 5.
PMID: 30737998 - Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer.
Kurashige J, Yokobori T, Mima K, Sawada G, Takahashi Y, Ueo H, Takano Y, Matsumura T, Uchi R, Eguchi H, Sudo T, Sugimachi K, Mori M, Baba H, Mimori K.
Oncol Lett. 2019 Feb;17(2):2393-2399. doi: 10.3892/ol.2018.9819. Epub 2018 Dec 11.
PMID: 30675305 - Age-related remodelling of oesophageal epithelia by mutated cancer drivers.
Yokoyama A, Kakiuchi N, Yoshizato T, Nannya Y, Suzuki H, Takeuchi Y, Shiozawa Y, Sato Y, Aoki K, Kim SK, Fujii Y, Yoshida K, Kataoka K, Nakagawa MM, Inoue Y, Hirano T, Shiraishi Y, Chiba K, Tanaka H, Sanada M, Nishikawa Y, Amanuma Y, Ohashi S, Aoyama I, Horimatsu T, Miyamoto S, Tsunoda S, Sakai Y, Narahara M, Brown JB, Sato Y, Sawada G, Mimori K, Minamiguchi S, Haga H, Seno H, Miyano S, Makishima H, Muto M, Ogawa S.
Nature. 2019 Jan;565(7739):312-317. doi: 10.1038/s41586-018-0811-x. Epub 2019 Jan 2.
PMID: 30602793 - CRMP5-associated GTPase (CRAG) Is a Candidate Driver Gene for Colorectal Cancer Carcinogenesis.
Shimizu D, Masuda T, Sato K, Tsuruda Y, Otsu H, Kuroda Y, Eguchi H, Kodera Y, Mimori K.
Anticancer Res. 2019 Jan;39(1):99-106. doi: 10.21873/anticanres.13084.
PMID: 30591445 - Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.
Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K.
Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):21-27. doi: 10.21873/cgp.20109.
PMID: 30587497 - 若年者乳癌女性への妊孕性温存情報提供の均てん化と紹介システムの構築
―おおいた乳がん・生殖ネットワーク設立後の成果―
久保田陽子 甲斐裕一郎 福永真理 増野浩二郎 末廣修治 田中仁寛 増田隆明 田中文明 藤吉健児 永松敏子 尾崎邦博 武内秀也 岡本正博 亀井美玲 森本章生 穴井秀明 宇都宮隆史 上尾裕昭
乳癌の臨床 第34巻第1号 81-87 2019
- ASO Author Reflections: ARL4C and Peritoneal Dissemination in Gastric Cancer.
Hu Q, Mimori K.
Ann Surg Oncol. 2018 Dec 17. doi: 10.1245/s10434-018-7056-7. [Epub ahead of print] No abstract available.
PMID: 30556117 - Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC).
Wakiyama H, Masuda T, Motomura Y, Hu Q, Tobo T, Eguchi H, Sakamoto K, Hirakawa M, Honda H, Mimori K.
Anticancer Res. 2018 Dec;38(12):6631-6638. doi: 10.21873/anticanres.13030.
PMID: 30504371 - Cancer evolution and heterogeneity.
Mimori K, Saito T, Niida A, Miyano S.
Ann Gastroenterol Surg. 2018 Jul 4;2(5):332-338. doi: 10.1002/ags3.12182. eCollection 2018 Sep. Review.
PMID: 30238073 - 食道癌のゲノム医療
大津甫, 三森功士
雑誌『外科』 80巻12号（2018年11月号） - Prognostic Impact of Immune-Related Gene Expression in Preoperative Peripheral Blood from Gastric Cancer Patients.
Ito S, Fukagawa T, Noda M, Hu Q, Nambara S, Shimizu D, Kuroda Y, Eguchi H, Masuda T, Sato T, Katai H, Sasako M, Mimori K.
Ann Surg Oncol. 2018 Sep 10. doi: 10.1245/s10434-018-6739-4. [Epub ahead of print]
PMID: 30203407 - Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy.
Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K.
Br J Cancer. 2018 Aug;119(4):419-423. doi: 10.1038/s41416-018-0208-5. Epub 2018 Aug 3.
PMID: 30072744 - Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T, Shinden Y, Noda M, Ueo H, Hu Q, Yoshikawa Y, Tsuruda Y, Kuroda Y, Ito S, Eguchi H, Ohno S, Mimori K.
Anticancer Res. 2018 Aug;38(8):4515-4523. doi: 10.21873/anticanres.12755.
PMID: 30061217 - A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer.
Saito T, Niida A, Uchi R, Hirata H, Komatsu H, Sakimura S, Hayashi S, Nambara S, Kuroda Y, Ito S, Eguchi H, Masuda T, Sugimachi K, Tobo T, Nishida H, Daa T, Chiba K, Shiraishi Y, Yoshizato T, Kodama M, Okimoto T, Mizukami K, Ogawa R, Okamoto K, Shuto M, Fukuda K, Matsui Y, Shimamura T, Hasegawa T, Doki Y, Nagayama S, Yamada K, Kato M, Shibata T, Mori M, Aburatani H, Murakami K, Suzuki Y, Ogawa S, Miyano S, Mimori K.
Nat Commun. 2018 Jul 23;9(1):2884. doi: 10.1038/s41467-018-05226-0.
PMID: 30038269 Free PMC Article - Overexpression of FGFR1 Promotes Peritoneal Dissemination Via Epithelial-to-Mesenchymal Transition in Gastric Cancer.
Shimizu D, Saito T, Ito S, Masuda T, Kurashige J, Kuroda Y, Eguchi H, Kodera Y, Mimori K.
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):313-320. doi: 10.21873/cgp.20089.
PMID: 29976636 - Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma.
Iguchi T, Ueda M, Masuda T, Nambara S, Kidogami S, Komatsu H, Sato K, Tobo T, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.
Oncology. 2018 Jun 15:1-9. doi: 10.1159/000488860. [Epub ahead of print]
PMID: 29909415 - PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
Kiyozumi Y, Iwatsuki M, Kurashige J, Ogata Y, Yamashita K, Koga Y, Toihata T, Hiyoshi Y, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Yanagihara K, Mimori K, Baba H.
Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410. [Epub ahead of print]
PMID: 29603227 - GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.
Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K.
Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.
PMID: 29471430 - Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.
Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.
Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.
PMID: 29423222 - Understanding intratumor heterogeneity by combining genome analysis and mathematical modeling.
Niida A, Nagayama S, Miyano S, Mimori K.
Cancer Sci. 2018 Apr;109(4):884-892. doi: 10.1111/cas.13510. Epub 2018 Feb 28. Review.
PMID: 29352488 - Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan.
Maeda T, Mimori K, Suzuki S, Horiuchi T, Makino N.
Sci Rep. 2018 Jan 9;8(1):133. doi: 10.1038/s41598-017-18488-3.
PMID: 29317745 - Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M.
Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.
PMID: 29282223 - Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K.
Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
PMID: 29270876
- Clinicopathological characteristics of disseminated carcinomatosis of the bone marrow in breast cancer patients.
Shinden Y, Sugimachi K, Tanaka F, Fujiyoshi K, Kijima Y, Natsugoe S, Mimori K.
Mol Clin Oncol. 2018 Jan;8(1):93-98. doi: 10.3892/mco.2017.1502. Epub 2017 Nov 15.
PMID: 29423222 - Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer.
Nambara S, Masuda T, Nishio M, Kuramitsu S, Tobo T, Ogawa Y, Hu Q, Iguchi T, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Saeki H, Oki E, Maehara Y, Suzuki A, Mimori K.
Oncotarget. 2017 Nov 21;8(64):107666-107677. doi: 10.18632/oncotarget.22587. eCollection 2017 Dec 8.
PMID: 29296196 - Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M.
Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27.
PMID: 29282223 - Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q, Masuda T, Sato K, Tobo T, Nambara S, Kidogami S, Hayashi N, Kuroda Y, Ito S, Eguchi H, Saeki H, Oki E, Maehara Y, Mimori K.
Ann Surg Oncol. 2018 Mar;25(3):745-753. doi: 10.1245/s10434-017-6292-6. Epub 2017 Dec 21.
PMID: 29270876 - Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer.
Takano Y, Masuda T, Iinuma H, Yamaguchi R, Sato K, Tobo T, Hirata H, Kuroda Y, Nambara S, Hayashi N, Iguchi T, Ito S, Eguchi H, Ochiya T, Yanaga K, Miyano S, Mimori K.
Oncotarget. 2017 Aug 7;8(45):78598-78613. doi: 10.18632/oncotarget.20009. eCollection 2017 Oct 3.
PMID: 29108252 - MicroRNAs as Biomarkers in Colorectal Cancer.
Masuda T, Hayashi N, Kuroda Y, Ito S, Eguchi H, Mimori K.
Cancers (Basel). 2017 Sep 13;9(9). pii: E124. doi: 10.3390/cancers9090124. Review.
PMID: 28902152 - Japanese genome-wide association study identifies a significant colorectal cancer susceptibility locus at chromosome 10p14.
Takahashi Y, Sugimachi K, Yamamoto K, Niida A, Shimamura T, Sato T, Watanabe M, Tanaka J, Kudo S, Sugihara K, Hase K, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Suzuki Y, Miyano S, Mori M, Mimori K.
Cancer Sci. 2017 Nov;108(11):2239-2247. doi: 10.1111/cas.13391. Epub 2017 Sep 26.
PMID: 28869801 - Diagnostic laparoscopy for pneumatosis intestinalis in a very elderly patient: A case report.
Ito S, Masuda T, Harada N, Matsuyama A, Hamatake M, Maeda T, Tsutsui S, Matsuda H, Mimori K, Ishida T.
Ann Med Surg (Lond). 2017 Jul 29;21:109-113. doi: 10.1016/j.amsu.2017.07.058. eCollection 2017 Sep.
PMID: 28861268 - Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma.
Nambara S, Masuda T, Tobo T, Kidogami S, Komatsu H, Sugimachi K, Saeki H, Oki E, Maehara Y, Mimori K.
Oncol Lett. 2017 Aug;14(2):1795-1801. doi: 10.3892/ol.2017.6341. Epub 2017 Jun 8.
PMID: 28789412 - Significance of CD47 expression in gastric cancer.
Sudo T, Takahashi Y, Sawada G, Uchi R, Mimori K, Akagi Y.
Oncol Lett. 2017 Jul;14(1):801-809. doi: 10.3892/ol.2017.6257. Epub 2017 May 26.
PMID: 28693236 - Long-term outcome of adipose-derived regenerative cell-enriched autologous fat transplantation for reconstruction after breast-conserving surgery for Japanese women with breast cancer.
Ito S, Kai Y, Masuda T, Tanaka F, Matsumoto T, Kamohara Y, Hayakawa H, Ueo H, Iwaguro H, Hedrick MH, Mimori K, Mori M.
Surg Today. 2017 Dec;47(12):1500-1511. doi: 10.1007/s00595-017-1544-4. Epub 2017 May 29.
PMID: 28555267 - Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.
Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.
PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May.
PMID: 28542232 - [MicroRNA in Various Aspects of Cancer Development].
Nambara S, Mimori K.
Gan To Kagaku Ryoho. 2017 May;44(5):362-366. Japanese.
PMID: 28536328 - DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer.
Sasaki S, Ueda M, Iguchi T, Kaneko M, Nakayama H, Watanabe T, Sakamoto A, Mimori K.
Anticancer Res. 2017 May;37(5):2587-2591.
PMID: 28476831 - Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer.
Sato K, Masuda T, Hu Q, Tobo T, Kidogami S, Ogawa Y, Saito T, Nambara S, Komatsu H, Hirata H, Sakimura S, Uchi R, Hayashi N, Iguchi T, Eguchi H, Ito S, Nakagawa T, Mimori K.
Anticancer Res. 2017 May;37(5):2365-2371.
PMID: 28476802 - Up-regulation of SLC9A9 Promotes Cancer Progression and Is Involved in Poor Prognosis in Colorectal Cancer.
Ueda M, Iguchi T, Masuda T, Komatsu H, Nambara S, Sakimura S, Hirata H, Uchi R, Eguchi H, Ito S, Sugimachi K, Mizushima T, Doki Y, Mori M, Mimori K.
Anticancer Res. 2017 May;37(5):2255-2263.
PMID: 28476790 - phyC: Clustering cancer evolutionary trees.
Matsui Y, Niida A, Uchi R, Mimori K, Miyano S, Shimamura T.
PLoS Comput Biol. 2017 May 1;13(5):e1005509. doi: 10.1371/journal.pcbi.1005509. eCollection 2017 May.
PMID: 28459850 - Overexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinoma.
Tsukao Y, Yamasaki M, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Miyata H, Nakajima K, Takiguchi S, Mimori K, Mori M, Doki Y.
Oncol Lett. 2017 Mar;13(3):1819-1825. doi: 10.3892/ol.2017.5637. Epub 2017 Jan 25.
PMID: 28454329 - The loss of CASP4 expression is associated with poor prognosis in esophageal squamous cell carcinoma.
Shibamoto M, Hirata H, Eguchi H, Sawada G, Sakai N, Kajiyama Y, Mimori K.
Oncol Lett. 2017 Mar;13(3):1761-1766. doi: 10.3892/ol.2017.5646. Epub 2017 Jan 25.
PMID: 28454321 - Altered Expression of Hippo Signaling Pathway Molecules in Intrahepatic Cholangiocarcinoma.
Sugimachi K, Nishio M, Aishima S, Kuroda Y, Iguchi T, Komatsu H, Hirata H, Sakimura S, Eguchi H, Bekki Y, Takenaka K, Maehara Y, Suzuki A, Mimori K.
Oncology. 2017;93(1):67-74. doi: 10.1159/000463390. Epub 2017 Apr 28.
PMID: 28448997 - Extraction of cell-free DNA from urine, using polylysine-coated silica particles.
Takano S, Hu Q, Amamoto T, Refinetti P, Mimori K, Funatsu T, Kato M.
Anal Bioanal Chem. 2017 Jun;409(16):4021-4025. doi: 10.1007/s00216-017-0345-3. Epub 2017 Apr 19.
PMID: 28424857 - MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.
Otsubo K, Goto H, Nishio M, Kawamura K, Yanagi S, Nishie W, Sasaki T, Maehama T, Nishina H, Mimori K, Nakano T, Shimizu H, Mak TW, Nakao K, Nakanishi Y, Suzuki A.
Oncogene. 2017 Jul 20;36(29):4201-4211. doi: 10.1038/onc.2017.58. Epub 2017 Mar 27.
PMID: 28346423 - Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
Komatsu H, Masuda T, Iguchi T, Nambara S, Sato K, Hu Q, Hirata H, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2017 Mar;37(3):1083-1090.
PMID: 28314268 - Clinical Impact of Tumor-Infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.
Sudo T, Nishida R, Kawahara A, Saisho K, Mimori K, Yamada A, Mizoguchi A, Kadoya K, Matono S, Mori N, Tanaka T, Akagi Y.
Ann Surg Oncol. 2017 Nov;24(12):3763-3770. doi: 10.1245/s10434-017-5796-4. Epub 2017 Feb 3.
PMID: 28160141 - Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.
Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.
Int J Oncol. 2017 Feb;50(2):441-447. doi: 10.3892/ijo.2016.3817. Epub 2016 Dec 22.
PMID: 28035351 - Overexpression of CXCR7 Is a Novel Prognostic Indicator in Gastric Cancer.
Nambara S, Iguchi T, Oki E, Tan P, Maehara Y, Mimori K.
Dig Surg. 2017;34(4):312-318. doi: 10.1159/000452977. Epub 2016 Dec 10.
PMID: 27941339 - The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.
Kasagi Y, Oki E, Ando K, Ito S, Iguchi T, Sugiyama M, Nakashima Y, Ohgaki K, Saeki H, Mimori K, Maehara Y.
Oncology. 2017;92(1):48-54. doi: 10.1159/000452143. Epub 2016 Nov 23.
PMID: 27875818 - Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Komatsu H, Iguchi T, Masuda T, Hirata H, Ueda M, Kidogami S, Ogawa Y, Sato K, Hu Q, Nambara S, Saito T, Sakimura S, Uchi R, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2017 Mar;24(3):850-859. doi: 10.1245/s10434-016-5573-9. Epub 2016 Oct 21.
PMID: 27770342 - As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma.
Desaki R, Sawada G, Okumura H, Ikeda R, Tanabe K, Komatsu H, Mimori K, Mori M, Kita Y, Uchikado Y, Arigami T, Uenosono Y, Owaki T, Ishigami S, Natsugoe S.
Ann Surg Oncol. 2017 Feb;24(2):586-593. doi: 10.1245/s10434-015-5031-0. Epub 2015 Dec 16.
PMID: 26676980
- Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.
Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.
Int J Oncol. 2017 Feb;50(2):441-447. doi: 10.3892/ijo.2016.3817. - Overexpression of CXCR7 Is a Novel Prognostic Indicator in Gastric Cancer.
Nambara S, Iguchi T, Oki E, Tan P, Maehara Y, Mimori K.
Dig Surg. 2016 Dec 10. doi:10.1159/000452977. - The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.
Kasagi Y, Oki E, Ando K, Ito S, Iguchi T, Sugiyama M, Nakashima Y, Ohgaki K, Saeki H, Mimori K, Maehara Y.
Oncology. 2017;92(1):48-54. doi: 10.1159/000452143. - miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients’ Susceptibility to Liver Metastasis.
Iguchi T, Nambara S, Masuda T, Komatsu H, Ueda M, Kidogami S, Ogawa Y, Hu Q, Sato K, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.
PLoS One. 2016 Nov 8;11(11):e0165912. doi: 10.1371/journal.pone.0165912. - Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Komatsu H, Iguchi T, Masuda T, Hirata H, Ueda M, Kidogami S, Ogawa Y, Sato K, Hu Q, Nambara S, Saito T, Sakimura S, Uchi R, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2016 Oct 21. - Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence.
Ueda M, Iguchi T, Masuda T, Nakahara Y, Hirata H, Uchi R, Niida A, Momose K, Sakimura S, Chiba K, Eguchi H, Ito S, Sugimachi K, Yamasaki M, Suzuki Y, Miyano S, Doki Y, Mori M, Mimori K.
Oncotarget. 2016 Aug 19. doi: 10.18632/oncotarget.11409. - HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
Colamaio M, Tosti N, Puca F, Mari A, Gattordo R, Kuzay Y, Federico A, Pepe A, Sarnataro D, Ragozzino E, Raia M, Hirata H, Gemei M, Mimori K, Del Vecchio L, Battista S, Fusco A.
Expert Opin Ther Targets. 2016 Oct;20(10):1169-79. doi: 10.1080/14728222.2016.1220543. - 8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis.
Sugimachi K, Yamaguchi R, Eguchi H, Ueda M, Niida A, Sakimura S, Hirata H, Uchi R, Shinden Y, Iguchi T, Morita K, Yamamoto K, Miyano S, Mori M, Maehara Y, Mimori K.
Ann Surg Oncol. 2016 Aug;23(Suppl 4):546-551. - HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
Colamaio M, Tosti N, Puca F, Mari A, Gattordo R, Kuzay Y, Federico A, Pepe A, Sarnataro D, Ragozzino E, Raia M, Hirata H, Gemei M, Mimori K, Del Vecchio L, Battista S, Fusco A.
Expert Opin Ther Targets. 2016 Oct;20(10):1169-79. doi: 10.1080/14728222.2016.1220543. - Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome.
Ito S, Okano S, Morita M, Saeki H, Tsutsumi S, Tsukihara H, Nakashima Y, Ando K, Imamura Y, Ohgaki K, Oki E, Kitao H, Mimori K, Maehara Y.
Ann Surg Oncol. 2016 Aug;23(Suppl 4):508-515. - Rapid diagnosis of lymph node metastasis in breast cancer using a new fluorescent method with γ-glutamyl hydroxymethyl rhodamine green.
Shinden Y, Ueo H, Tobo T, Gamachi A, Utou M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.
Sci Rep. 2016 Jun 9;6:27525. doi: 10.1038/srep27525. - HOXB7 Expression is a Novel Biomarker for Long-term Prognosis After Resection of Hepatocellular Carcinoma.
Komatsu H, Iguchi T, Masuda T, Ueda M, Kidogami S, Ogawa Y, Nambara S, Sato K, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2016 Jun;36(6):2767-73. - Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
Sugimachi K, Matsumura T, Shimamura T, Hirata H, Uchi R, Ueda M, Sakimura S, Iguchi T, Eguchi H, Masuda T, Morita K, Takenaka K, Maehara Y, Mori M, Mimori K.
Ann Surg Oncol. 2016 Nov;23(12):3948-3955. - Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H, Sugimachi K, Komatsu H, Ueda M, Masuda T, Uchi R, Sakimura S, Nambara S, Saito T, Shinden Y, Iguchi T, Eguchi H, Ito S, Terashima K, Sakamoto K, Hirakawa M, Honda H, Mimori K.
Cancer Res. 2016 Jun 1;76(11):3265-76. doi: 10.1158/0008-5472.CAN-15-2601. - Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
Iguchi T, Komatsu H, Masuda T, Nambara S, Kidogami S, Ogawa Y, Hu Q, Saito T, Hirata H, Sakimura S, Uchi R, Hayashi N, Ito S, Eguchi H, Sugimachi K, Maehara Y, Mimori K.
Anticancer Res. 2016 May;36(5):2139-44. - Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Nakahara Y, Yamasaki M, Sawada G, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mimori K, Mori M, Doki Y.
Oncology. 2016;90(6):347-55. doi: 10.1159/000445323. - Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
Kurashige J, Hasegawa T, Niida A, Sugimachi K, Deng N, Mima K, Uchi R, Sawada G, Takahashi Y, Eguchi H, Inomata M, Kitano S, Fukagawa T, Sasako M, Sasaki H, Sasaki S, Mori M, Yanagihara K, Baba H, Miyano S, Tan P, Mimori K.
Sci Rep. 2016 Mar. 3;6:22371. - Clinical and biological significance of circulating tumor cells in cancer.
Masuda T, Hayashi N, Iguchi T, Ito S, Eguchi H, Mimori K.
Mol Oncol. 2016 Mar.10(3):408-17. - Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.
Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.
PLoS Genet. 2016 Feb.18;12(2):e1005778. - Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.
Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, Iwaya T, Sudo T, Hayashi T, Takai H, Kawasaki Y, Matsukawa T, Eguchi H, Sugimachi K, Tanaka F, Suzuki H, Yamamoto K, Ishii H, Shimizu M, Yamazaki H, Yamazaki M, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Mafune K, Tanaka Y, Kelsell DP, Scott CA, Tsuji S, Yachida S, Shibata T, Sugano S, Doki Y, Akiyama T, Aburatani H, Ogawa S, Miyano S, Mori M, Mimori K.
Gastroenterology. 2016 Feb. S0016-5085(16)00134-7. - Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H, Iguchi T, Ueda M, Nambara S, Saito T, Hirata H, Sakimura S, Takano Y, Uchi R, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Eguchi H, Doki Y, Mori M, Mimori K.
Oncol Rep. 2016 Apr;35(4):2073-80. doi: 10.3892/or.2016.4593. - Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, Takano Y, Hikasa H, Itoh T, Suzuki SO, Kurihara H, Aishima S, Leask A, Sasaki T, Nakano T, Nishina H, Nishikawa Y, Sekido Y, Nakao K, Shin-Ya K, Mimori K, Suzuki A.
Proc Natl Acad Sci USA. 2016 Jan. 5;113(1):E71-80. - As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma.
Desaki R, Sawada G, Okumura H, Ikeda R, Tanabe K, Komatsu H, Mimori K, Mori M, Kita Y, Uchikado Y, Arigami T, Uenosono Y, Owaki T, Ishigami S, Natsugoe S.
Ann Surg Oncol. 2015 Dec 16.
- An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma.
Sawada G, Niida A, Hirata H, Komatsu H, Uchi R, Shimamura T, Takahashi Y, Kurashige J, Matsumura T, Ueo H, Takano Y, Ueda M, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Yamasaki M, Tanaka F, Tachimori Y, Kajiyama Y, Natsugoe S, Fujita H, Tanaka Y, Calin G, Miyano S, Doki Y, Mori M, Mimori K.
PLoS One. 2015 Oct 14;10(10):e0139808. doi: 10.1371/journal.pone.0139808. eCollection 2015. - Identification of Recurrence-Related microRNAs from Bone Marrow in Hepatocellular Carcinoma Patients.
Sugimachi K, Sakimura S, Tomokuni A, Uchi R, Hirata H, Komatsu H, Shinden Y, Iguchi T, Eguchi H, Masuda T, Morita K, Shirabe K, Eguchi H, Maehara Y, Mori M, Mimori K.
J Clin Med. 2015 Aug 14;4(8):1600-11. doi: 10.3390/jcm4081600. - Embryonic MicroRNA-369 Controls Metabolic Splicing Factors and Urges Cellular Reprograming.
Konno M, Koseki J, Kawamoto K, Nishida N, Matsui H, Dewi DL, Ozaki M, Noguchi Y, Mimori K, Gotoh N, Tanuma N, Shima H, Doki Y, Mori M, Ishii H.
PLoS One. 2015 Jul 15;10(7):e0132789. doi: 10.1371/journal.pone.0132789. eCollection 2015. - miR-29b is an indicator of prognosis in breast cancer patients.
Shinden Y, Iguchi T, Akiyoshi S, Ueo H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Eguchi H, Sugimachi K, Kijima Y, Natsugoe S, Mimori K.
Mol Clin Oncol. 2015 Jul;3(4):919-923. Epub 2015 May 12. - Rapid intraoperative visualization of breast lesions with γ-glutamyl hydroxymethyl rhodamine green.
Ueo H, Shinden Y, Tobo T, Gamachi A, Udo M, Komatsu H, Nambara S, Saito T, Ueda M, Hirata H, Sakimura S, Takano Y, Uchi R, Kurashige J, Akiyoshi S, Iguchi T, Eguchi H, Sugimachi K, Kubota Y, Kai Y, Shibuta K, Kijima Y, Yoshinaka H, Natsugoe S, Mori M, Maehara Y, Sakabe M, Kamiya M, Kakareka JW, Pohida TJ, Choyke PL, Kobayashi H, Ueo H, Urano Y, Mimori K.
Sci Rep. 2015 Jul 13;5:12080. doi: 10.1038/srep12080. - miR-615-3p expression level in bone marrow is associated with tumor recurrence in hepatocellular carcinoma.
Mukai R, Tomimaru Y, Nagano H, Eguchi H, Mimori K, Tomokuni A, Asaoka T, Wada H, Kawamoto K, Marubashi S, Doki Y, Mori M.
Mol Clin Oncol. 2015 May;3(3):487-494. Epub 2015 Feb 25. - Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
Matsumura T, Sugimachi K, Iinuma H, Takahashi Y, Kurashige J, Sawada G, Ueda M, Uchi R, Ueo H, Takano Y, Shinden Y, Eguchi H, Yamamoto H, Doki Y, Mori M, Ochiya T, Mimori K.
Br J Cancer. 2015 Jul 14;113(2):275-81. doi: 10.1038/bjc.2015.201. Epub 2015 Jun 9. - Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer.
Ueda M, Iguchi T, Nambara S, Saito T, Komatsu H, Sakimura S, Hirata H, Uchi R, Takano Y, Shinden Y, Eguchi H, Masuda T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2015 Jun 3. [Epub ahead of print] - A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T, Kurashige J, Nambara S, Komatsu H, Hirata H, Ueda M, Sakimura S, Uchi R, Takano Y, Shinden Y, Iguchi T, Eguchi H, Ehata S, Murakami K, Sugimachi K, Mimori K.
Ann Surg Oncol. 2015 May 19. [Epub ahead of print] - [Cancer stemness and circulating tumor cells].
Saito T, Mimori K.
Nihon Rinsho. 2015 May;73(5):806-10. Japanese. - Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
Takahashi H, Nishimura J, Kagawa Y, Kano Y, Takahashi Y, Wu X, Hiraki M, Hamabe A, Konno M, Haraguchi N, Takemasa I, Mizushima T, Ishii M, Mimori K, Ishii H, Doki Y, Mori M, Yamamoto H.
Mol Cancer Ther. 2015 Jul;14(7):1705-16. doi: 10.1158/1535-7163.MCT-14-0142. Epub 2015 Apr 22. - Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer.
Ueo H, Sugimachi K, Gorges TM, Bartkowiak K, Yokobori T, M?ller V, Shinden Y, Ueda M, Ueo H, Mori M, Kuwano H, Maehara Y, Ohno S, Pantel K, Mimori K.
Br J Cancer. 2015 Apr 28;112(9):1519-26. doi: 10.1038/bjc.2015.132. Epub 2015 Apr 16. - Intestinal epithelial culture under an air-liquid interface: a tool for studying human and mouse esophagi.
Yokobori T, Suzuki S, Miyazaki T, Sohda M, Sakai M, Tanaka N, Ozawa D, Hara K, Honjo H, Altan B, Fukuchi M, Ishii H, Iwatsuki M, Sugimachi K, Sudo T, Iwaya T, Nishida N, Mimori K, Kuwano H, Mori M.
Dis Esophagus. 2015 Mar 23. doi: 10.1111/dote.12346. [Epub ahead of print] - A Highly Accurate Inclusive Cancer Screening Test Using Caenorhabditis elegans Scent Detection.
Hirotsu T, Sonoda H, Uozumi T, Shinden Y, Mimori K, Maehara Y, Ueda N, Hamakawa M.
PLoS One. 2015 Mar 11;10(3):e0118699. doi: 10.1371/journal.pone.0118699. eCollection 2015. - A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer.
Iguchi T, Uchi R, Nambara S, Saito T, Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, Shinden Y, Eguchi H, Sugimachi K, Maehara Y, Mimori K.
Anticancer Res. 2015 Mar;35(3):1385-8. - The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer.
Sakimura S, Sugimachi K, Kurashige J, Ueda M, Hirata H, Nambara S, Komatsu H, Saito T, Takano Y, Uchi R, Sakimura E, Shinden Y, Iguchi T, Eguchi H, Oba Y, Hoka S, Mimori K.
Ann Surg Oncol. 2015 Feb 24. [Epub ahead of print] - F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.
Yumimoto K, Akiyoshi S, Ueo H, Sagara Y, Onoyama I, Ueo H, Ohno S, Mori M, Mimori K, Nakayama KI.
J Clin Invest. 2015 Feb;125(2):621-35. doi: 10.1172/JCI78782. Epub 2015 Jan 2. - Diminished expression of MiR-15a is an independent prognostic marker for breast cancer cases.
Shinden Y, Akiyoshi S, Ueo H, Nambara S, Saito T, Komatsu H, Ueda M, Hirata H, Sakimura S, Uchi R, Takano Y, Iguchi T, Eguchi H, Sugimachi K, Kijima Y, Ueo H, Natsugoe S, Mimori K.
Anticancer Res. 2015 Jan;35(1):123-7. - Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J, Mima K, Sawada G, Takahashi Y, Eguchi H, Sugimachi K, Mori M, Yanagihara K, Yashiro M, Hirakawa K, Baba H, Mimori K.
Carcinogenesis. 2015 Jan;36(1):133-41. doi: 10.1093/carcin/bgu232. Epub 2014 Nov 19.
- Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H, Sugimachi K, Takahashi Y, Ueda M, Sakimura S, Uchi R, Kurashige J, Takano Y, Nanbara S, Komatsu H, Saito T, Shinden Y, Iguchi T, Eguchi H, Atsumi K, Sakamoto K, Doi T, Hirakawa M, Honda H, Mimori K.
Ann Surg Oncol. 2014 Nov 18. [Epub ahead of print] - Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition.
Hamabe A, Konno M, Tanuma N, Shima H, Tsunekuni K, Kawamoto K, Nishida N, Koseki J, Mimori K, Gotoh N, Yamamoto H, Doki Y, Mori M, Ishii H.
Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15526-31. doi: 10.1073/pnas.1407717111. Epub 2014 Oct 13. - MACC1 expression levels as a novel prognostic marker for colorectal cancer.
Yamamoto H, Miyoshi N, Mimori K, Hitora T, Tokuoka M, Fujino S, Ellis HL, Ishii H, Noura S, Ohue M, Yano M, Doki Y, Mori M.
Oncol Lett. 2014 Nov;8(5):2305-2309. Epub 2014 Aug 19. - ANXA9 gene expression in colorectal cancer: A novel marker for prognosis.
Miyoshi N, Yamamoto H, Mimori K, Yamashita S, Miyazaki S, Nakagawa S, Ishii H, Noura S, Ohue M, Yano M, Doki Y, Mori M.
Oncol Lett. 2014 Nov;8(5):2313-2317. Epub 2014 Aug 25. - Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer.
Ueda M, Takahashi Y, Shinden Y, Sakimura S, Hirata H, Uchi R, Takano Y, Kurashige J, Iguchi T, Eguchi H, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2014 Oct;34(10):5357-62. - Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
Kondo Y, Iwao T, Yoshihashi S, Mimori K, Ogihara R, Nagata K, Kurose K, Saito M, Niwa T, Suzuki T, Miyata N, Ohmori S, Nakamura K, Matsunaga T.
PLoS One. 2014 Aug 1;9(8):e104010. doi: 10.1371/journal.pone.0104010. eCollection 2014. - Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer.
Matsumura T, Sugimachi K, Takahashi Y, Uchi R, Sawada G, Ueda M, Hirata H, Sakimura S, Ueo H, Takano Y, Kurashige J, Shinden Y, Eguchi H, Sudo T, Yamamoto H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 Dec;21 Suppl 4:S743-9. doi: 10.1245/s10434-014-3889-x. Epub 2014 Jul 17. - A single nucleotide polymorphism in fibronectin?1 determines tumor shape in colorectal cancer.
Kida H, Takano Y, Yamamoto K, Mori M, Yanaga K, Tanaka J, Kudo SE, Mimori K.
Oncol Rep. 2014 Aug;32(2):548-52. doi: 10.3892/or.2014.3251. Epub 2014 Jun 12. - Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
Okano M, Konno M, Kano Y, Kim H, Kawamoto K, Ohkuma M, Haraguchi N, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y, Mori M, Ishii H.
Int J Oncol. 2014 Aug;45(2):575-80. doi: 10.3892/ijo.2014.2462. Epub 2014 May 23. - Loss of CDCP1 Expression Promotes Invasiveness and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Sawada G, Takahashi Y, Niida A, Shimamura T, Kurashige J, Matsumura T, Ueo H, Uchi R, Takano Y, Ueda M, Hirata H, Sakimura S, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Miyano S, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 May 22. [Epub ahead of print] - A case of gastric plexiform fibromyxoma: radiological and pathological findings.
Sakamoto K, Hirakawa M, Atsumi K, Mimori K, Shibata K, Tobo T, Yamamoto H, Honda H.
Jpn J Radiol. 2014 Apr 18. [Epub ahead of print] - Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
Kita Y, Nishizono Y, Okumura H, Uchikado Y, Sasaki K, Matsumoto M, Setoyama T, Tanoue K, Omoto I, Mori S, Owaki T, Ishigami S, Nakagawa H, Tanaka F, Mimori K, Mori M, Natsugoe S.
Oncol Rep. 2014 May;31(5):1986-92. doi: 10.3892/or.2014.3062. Epub 2014 Mar 5. - Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer.
Takeyama H, Yamamoto H, Yamashita S, Wu X, Takahashi H, Nishimura J, Haraguchi N, Miyake Y, Suzuki R, Murata K, Ohue M, Kato T, Takemasa I, Mizushima T, Ishii H, Mimori K, Doki Y, Mori M.
Mol Cancer Ther. 2014 Apr;13(4):976-85. doi: 10.1158/1535-7163.MCT-13-0571. Epub 2014 Jan 21. - Allelic Imbalance at an 8q24 Oncogenic SNP is Involved in Activating MYC in Human Colorectal Cancer.
Sugimachi K, Niida A, Yamamoto K, Shimamura T, Imoto S, Iinuma H, Shinden Y, Eguchi H, Sudo T, Watanabe M, Tanaka J, Kudo S, Hase K, Kusunoki M, Yamada K, Shimada Y, Sugihara K, Maehara Y, Miyano S, Mori M, Mimori K.
Ann Surg Oncol. 2014 Jan 6. [Epub ahead of print] - Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
Takahashi Y, Iwaya T, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Ann Surg Oncol. 2014 Jan;21(1):205-12. doi: 10.1245/s10434-013-3264-3. Epub 2013 Sep 18.
- [Identification of genes that predict lymph node metastasis in colorectal cancer cases].
Ueo H, Takano Y, Matsumura T, Kurashige J, Shinden Y, Eguchi H, Sudo T, Sugimachi K, Saeki H, Oki E, Morita M, Ikeda T, Maehara Y, Mimori K.
Fukuoka Igaku Zasshi. 2013 Dec;104(12):559-63. Japanese. - Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).
Yoshinaga K, Saeki H, Oki E, Morita M, Ikeda T, Sugimachi K, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Soejima Y, Kawanaka H, Mimori K, Watanabe M, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Dec;104(12):549-58. - Pilot study of preoperative immunonutrition with antioxidants in living donor liver transplantation donors.
Nagata S, Shirabe K, Sugimachi K, Ikegami T, Yoshizumi T, Uchiyama H, Yamashita Y, Saeki H, Kawanaka H, Mimori K, Watanabe M, Gion T, Soejima Y, Ikeda T, Tsujitani S, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Dec;104(12):530-8. - Evaluation of a transection method for distal pancreatectomy: A comparative study on the use of electrosurgical and stapling devices in swine.
Ikeda T, Akahoshi T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Saeki H, Sugimachi K, Ikegami T, Yoshizumi T, Soejima Y, Shirabe K, Mimori K, Watanabe M, Hashizume M, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Dec;104(12):515-22. - [Optimum hepatic parenchymal dissection to prevent bile leak: a comparative study using electrosurgical and stapling devices in swine].
Ikeda T, Akahoshi T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Saeki H, Sugimachi K, Ikegami T, Yoshizumi T, Soejima Y, Shirabe K, Mimori K, Watanabe M, Hashizume M, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Dec;104(12):507-14. Japanese. - Rex shunt for portal vein thrombosis after adult living donor liver transplantation.
Soejima Y, Shirabe K, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Ikeda T, Kawanaka H, Sugimachi K, Mimori K, Watanabe M, Morita M, Oki E, Saeki H, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Nov;104(11):464-8. - Large simple hepatic cysts leading to gastric fundal varices in a noncirrhotic patient.
Kinjo N, Yano H, Sugimachi K, Tanaka J, Tanaka K, Saeki H, Tsukamoto S, Mimori K, Kawanaka H, Ikebe M, Morita M, Ikeda T, Mu S, Higashi H, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Nov;104(11):449-55. - Successful treatment of primary jejunal cancer after esophageal and colon cancer resection.
Egashira A, Taguchi K, Toh Y, Yamamoto M, Okamura T, Saeki H, Oki E, Morita M, Ikeda T, Mimori K, Watanabe M, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Nov;104(11):435-41. - Relevance of totally laparoscopic gastrectomy for patients with advanced gastric cancer.
Saeki H, Oki E, Tsuda Y, Ando K, Hiyoshi Y, Itoh S, Morita M, Ikeda T, Sugimachi K, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Soejima Y, Kawanaka H, Mimori K, Watanabe M, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Nov;104(11):405-12. - Thoracoscopic pericardial drainage for gastric tube ulcer penetrated into the pericardium.
Watanabe M, Matsuura K, Baba H, Yoshizumi T, Ikegami T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Mimori K, Sugimachi K, Saeki H, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Oct;104(10):389-93. - Effect of CD133-positive stem cells in repeated recurrence of hepatocellular carcinoma after liver transplantation: a case report.
Toshima T, Yoshizumi T, Uchiyama H, Ikegami T, Soejima Y, Ikeda T, Kawanaka H, Yamashita Y, Morita M, Oki E, Mimori K, Sugimachi K, Saeki H, Watanabe M, Shirabe K, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Oct;104(10):383-8. - Recurrent hepatitis B following recurrence of hepatocellular carcinoma after living donor liver transplantation.
Ijichi H, Yoshizumi T, Ikegami T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Mimori K, Sugimachi K, Saeki H, Watanabe M, Shirabe K, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Oct;104(10):376-82. - Suppression of MAL gene expression in gastric cancer correlates with metastasis and mortality.
Kurashige J, Sawada G, Takahashi Y, Eguchi H, Sudo T, Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Saeki H, Sugimachi K, Watanabe M, Mori M, Baba H, Mimori K.
Fukuoka Igaku Zasshi. 2013 Oct;104(10):344-9. - Identification of the NEDD4L Gene as a Prognostic Marker by Integrated Microarray Analysis of Copy Number and Gene Expression Profiling in Non-small Cell Lung Cancer.
Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S590-8. doi: 10.1245/s10434-013-3059-6. Epub 2013 Jun 28. - Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo.
Kagawa Y, Matsumoto S, Kamioka Y, Mimori K, Naito Y, Ishii T, Okuzaki D, Nishida N, Maeda S, Naito A, Kikuta J, Nishikawa K, Nishimura J, Haraguchi N, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Ishii H, Doki Y, Matsuda M, Kikuchi A, Mori M, Ishii M.
PLoS One. 2013 Dec 30;8(12):e83629. doi: 10.1371/journal.pone.0083629. eCollection 2013. - Case of early adenosquamous carcinoma of the stomach.
Kimura Y, Matsuda H, Saeki H, Oki E, Morita M, Sugimachi K, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T, Soejima Y, Kawanaka H, Ikeda T, Tsutsui S, Fujihara M, Mimori K, Watanabe M, Ishida T, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Sep;104(9):315-20. Review. - Total laparoscopic distal gastrectomy for elderly patients with gastric cancer.
Oki E, Sakaguchi Y, Ohgaki K, Saeki H, Ikegami T, Minami K, Yamashita Y, Toh Y, Soejima Y, Ando K, Mimori K, Watanabe M, Sugimachi K, Uchiyama H, Yoshizumi T, Kawanaka H, Morita M, Ikeda T, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Sep;104(9):290-8. - Application of splenectomy to decompress portal pressure in left lobe living donor liver transplantation.
Ikegami T, Yoshizumi T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Saeki H, Mimori K, Sugimachi K, Watanabe M, Shirabe K, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Sep;104(9):282-9. - Aberrant Expression of Plastin-3 Via Copy Number Gain Induces the Epithelial-Mesenchymal Transition in Circulating Colorectal Cancer Cells.
Sugimachi K, Yokobori T, Iinuma H, Ueda M, Ueo H, Shinden Y, Eguchi H, Sudo T, Suzuki A, Maehara Y, Mori M, Mimori K.
Ann Surg Oncol. 2013 Nov 12. [Epub ahead of print] - Gene expression of bone morphogenic protein 8B in the primary site, peripheral blood and bone marrow of patients with gastric cancer.
Mima K, Fukagawa T, Kurashige J, Takano Y, Uchi R, Ueo H, Matsumura T, Ishibashi M, Sawada G, Takahashi Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Watanabe M, Ishii H, Mori M, Baba H, Sasako M, Mimori K.
Oncol Lett. 2013 Aug;6(2):387-392. Epub 2013 Jun 12. - Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.
Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K, Endo F, Katagiri H, Ishida K, Kume K, Nishizuka S, Iinuma H, Wakabayashi G, Mori M, Sasako M, Mimori K.
Clin Cancer Res. 2013 Dec 1;19(23):6438-49. doi: 10.1158/1078-0432.CCR-12-3186. Epub 2013 Oct 4. - Significance of INHBA expression in human colorectal cancer.
Okano M, Yamamoto H, Ohkuma H, Kano Y, Kim H, Nishikawa S, Konno M, Kawamoto K, Haraguchi N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Sekimoto M, Doki Y, Mori M, Ishii H.
Oncol Rep. 2013 Dec;30(6):2903-8. doi: 10.3892/or.2013.2761. Epub 2013 Oct 1. - Loss of COP1 expression determines poor prognosisin patients with gastric cancer.
Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.
Oncol Rep. 2013 Oct;30(4):1971-5. doi: 10.3892/or.2013.2664. Epub 2013 Aug 8. - Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.
Takahashi Y, Sawada G, Sato T, Kurashige J, Mima K, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Eguchi H, Sudo T, Sugimachi K, Tanaka J, Kudo SE, Doki Y, Mori M, Mimori K.
Oncol Rep. 2013 Sep;30(3):1488-96. doi: 10.3892/or.2013.2602. Epub 2013 Jul 8. - CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.
Sawada G, Ueo H, Matsumura T, Uchi R, Ishibashi M, Mima K, Kurashige J, Takahashi Y, Akiyoshi S, Sudo T, Sugimachi K, Doki Y, Mori M, Mimori K.
Oncol Rep. 2013 Sep;30(3):1137-42. doi: 10.3892/or.2013.2597. Epub 2013 Jul 8. - EGFR gets in the way of microRNA biogenesis.
Nishida N, Mimori K, Mori M, Calin GA.
Cell Res. 2013 Oct;23(10):1157-8. doi: 10.1038/cr.2013.87. Epub 2013 Jul 9. - Capturing the mammalian Hippo: elucidating its role in cancer.
Nishio M, Otsubo K, Maehama T, Mimori K, Suzuki A.
Cancer Sci. 2013 Oct;104(10):1271-7. doi: 10.1111/cas.12227. Epub 2013 Aug 7. - Biological and molecular aspects of lymph node metastasis in gastro-intestinal cancer.
Mimori K, Shinden Y, Eguchi H, Sudo T, Sugimachi K.
Int J Clin Oncol. 2013 Oct;18(5):762-5. doi: 10.1007/s10147-013-0587-9. Epub 2013 Jul 5. Review. - Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
Sakashita H, Inoue H, Akamine S, Ishida T, Inase N, Shirao K, Mori M, Mimori K.
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S590-8. doi: 10.1245/s10434-013-3059-6. Epub 2013 Jun 28. - CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer.
Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gaf? R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, Zhang X, Ferracin M, Churchman M, van Galen JF, Beverloo BH, Shariati M, Haderk F, Estecio MR, Garcia-Manero G, Patijn GA, Gotley DC, Bhardwaj V, Shureiqi I, Sen S, Multani AS, Welsh J, Yamamoto K, Taniguchi I, Song MA, Gallinger S, Casey G, Thibodeau SN, Le Marchand L, Tiirikainen M, Mani SA, Zhang W, Davuluri RV, Mimori K, Mori M, Sieuwerts AM, Martens JW, Tomlinson I, Negrini M, Berindan-Neagoe I, Foekens JA, Hamilton SR, Lanza G, Kopetz S, Fodde R, Calin GA.
Genome Res. 2013 Sep;23(9):1446-61. doi: 10.1101/gr.152942.112. Epub 2013 Jun 24. - CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
Haraguchi N, Ishii H, Mimori K, Ohta K, Uemura M, Nishimura J, Hata T, Takemasa I, Mizushima T, Yamamoto H, Doki Y, Mori M.
Int J Oncol. 2013 Aug;43(2):425-30. doi: 10.3892/ijo.2013.1955. Epub 2013 May 24. - Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi Y, Sawada G, Kurashige J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M, Mimori K.
Anticancer Res. 2013 May;33(5):1927-34. - Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Ishibashi M, Kogo R, Shibata K, Ueo H, Uchi R, Matsumura T, Takano Y, Sawada G, Takahashi Y, Mima K, Kurashige J, Akiyoshi S, Iwaya T, Eguchi H, Sudo T, Sugimachi K, Suzuki A, Wakabayashi G, Mori M, Mimori K.
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S537-44. doi: 10.1245/s10434-013-2958-x. Epub 2013 Mar 27.
Select item 23378342 - Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yokobori T, Iinuma H, Shimamura T, Imoto S, Sugimachi K, Ishii H, Iwatsuki M, Ota D, Ohkuma M, Iwaya T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Toh H, Sato T, Barnard GF, Fukagawa T, Yamamoto S, Nakanishi H, Sasaki S, Miyano S, Watanabe T, Kuwano H, Mimori K, Pantel K, Mori M.
Cancer Res. 2013 Apr 1;73(7):2059-69. doi: 10.1158/0008-5472.CAN-12-0326. Epub 2013 Feb 1. - Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.
Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, Sugimachi K, Mimori K, Wakabayashi G, Mori M.
Oncol Rep. 2013 Mar;29(3):946-50. doi: 10.3892/or.2012.2219. Epub 2012 Dec 28. - Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer.
Yamamoto H, Tei M, Uemura M, Takemasa I, Uemura Y, Murata K, Fukunaga M, Ohue M, Ohnishi T, Ikeda K, Kato T, Okamura S, Ikenaga M, Haraguchi N, Nishimura J, Mizushima T, Mimori K, Doki Y, Mori M.
Int J Oncol. 2013 Feb;42(2):549-55. doi: 10.3892/ijo.2012.1750. Epub 2012 Dec 21. - Significance of hepatic resection for hepatocellular carcinoma with sustained virological response to interferon therapy for chronic hepatitis C.
Sugimachi K, Kinjo N, Ikebe M, Yamashita N, Kajiwara E, Mimori K, Higashi H.
Hepatol Res. 2013 Jun;43(6):605-9. doi: 10.1111/j.1872-034X.2012.01112.x. Epub 2012 Nov 12. - Laparoscopic surgery minimizes the surgical manipulation of isolated tumor cells leading to decreased metastasis compared to open surgery for colorectal cancer.
Akiyoshi S, Mimori K, Sudo T, Tanaka F, Shibata K, Mori M.
Surg Today. 2013 Jan;43(1):20-5. doi: 10.1007/s00595-012-0389-0. Epub 2012 Oct 27. - The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, Iinuma H, Ishimaru S, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Miyano S, Sugihara K, Mori M.
Ann Surg Oncol. 2013 Apr;20(4):1395-402. doi: 10.1245/s10434-012-2657-z. Epub 2012 Sep 14. - Expression of mesenchymal markers vimentin and fibronectin: the clinical significance in esophageal squamous cell carcinoma.
Sudo T, Iwaya T, Nishida N, Sawada G, Takahashi Y, Ishibashi M, Shibata K, Fujita H, Shirouzu K, Mori M, Mimori K.
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S324-35. doi: 10.1245/s10434-012-2418-z. Epub 2012 May 30.
- Biological and clinical availability of adipose-derived stem cells for pelvic dead space repair.
Takahashi H, Haraguchi N, Nishikawa S, Miyazaki S, Suzuki Y, Mizushima T, Nishimura J, Takemasa I, Yamamoto H, Mimori K, Ishii H, Doki Y, Mori M.
Stem Cells Transl Med. 2012 Nov;1(11):803-10. doi: 10.5966/sctm.2012-0085. Epub 2012 Oct 23. - Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.
Nishio M, Hamada K, Kawahara K, Sasaki M, Noguchi F, Chiba S, Mizuno K, Suzuki SO, Dong Y, Tokuda M, Morikawa T, Hikasa H, Eggenschwiler J, Yabuta N, Nojima H, Nakagawa K, Hata Y, Nishina H, Mimori K, Mori M, Sasaki T, Mak TW, Nakano T, Itami S, Suzuki A.
J Clin Invest. 2012 Dec 3;122(12):4505-18. doi: 10.1172/JCI63735. Epub 2012 Nov 12. - Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer.
Kosaka Y, Kataoka A, Yamaguchi H, Ueo H, Akiyoshi S, Sengoku N, Kuranami M, Ohno S, Watanabe M, Mimori K, Mori M.
Breast Cancer Res. 2012 Oct 31;14(5):R140. doi: 10.1186/bcr3345. - microRNA-181a is associated with poor prognosis of colorectal cancer.
Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Ishii H, Doki Y, Mori M.
Oncol Rep. 2012 Dec;28(6):2221-6. doi: 10.3892/or.2012.2059. Epub 2012 Sep 26. - Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway.
Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, Wakabayashi G, Mori M, Mimori K.
Carcinogenesis. 2012 Dec;33(12):2391-7. doi: 10.1093/carcin/bgs288. Epub 2012 Sep 15. - [Significance of genome-wide association study in cancer].
Takahashi Y, Mimori K, Mori M.
Nihon Geka Gakkai Zasshi. 2012 Mar;113(2):210-4. Review. Japanese. - [Current topics in mutations in the cancer genome].
Iwaya T, Mimori K, Wakabayashi G.
Nihon Geka Gakkai Zasshi. 2012 Mar;113(2):185-90. Review. Japanese. - Genomic copy number of a carcinogenic single nucleotide polymorphism at 8q24 in non-risk allele colorectal cancer associated with insulin growth factor 2 receptor expression.
Takahashi Y, Mimori K, Yamamoto K, Watanabe M, Tanaka J, Kudo SE, Sugihara K, Hase K, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Mori M.
J Gastroenterol Hepatol. 2012 Apr;27 Suppl 3:95-9. doi: 10.1111/j.1440-1746.2012.07081.x. - Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T, Mimori K, Iwatsuki M, Ishii H, Tanaka F, Sato T, Toh H, Sudo T, Iwaya T, Tanaka Y, Onoyama I, Kuwano H, Nakayama KI, Mori M.
Int J Oncol. 2012 Jul;41(1):253-9. doi: 10.3892/ijo.2012.1436. Epub 2012 Apr 19. - MicroRNA-372 is associated with poor prognosis in colorectal cancer.
Yamashita S, Yamamoto H, Mimori K, Nishida N, Takahashi H, Haraguchi N, Tanaka F, Shibata K, Sekimoto M, Ishii H, Doki Y, Mori M.
Oncology. 2012;82(4):205-12. doi: 10.1159/000336809. Epub 2012 Mar 26. - Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters.
Nishida N, Nagahara M, Sato T, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Sugihara K, Doki Y, Mori M.
Clin Cancer Res. 2012 Jun 1;18(11):3054-70. doi: 10.1158/1078-0432.CCR-11-1078. Epub 2012 Mar 27. - Increased risk for CRC in diabetic patients with the nonrisk allele of SNPs at 8q24.
Ishimaru S, Mimori K, Yamamoto K, Inoue H, Imoto S, Kawano S, Yamaguchi R, Sato T, Toh H, Iinuma H, Maeda T, Ishii H, Suzuki S, Tokudome S, Watanabe M, Tanaka J, Kudo SE, Sugihara K, Hase K, Mochizuki H, Kusunoki M, Yamada K, Shimada Y, Moriya Y, Barnard GF, Miyano S, Mori M.
Ann Surg Oncol. 2012 Sep;19(9):2853-8. doi: 10.1245/s10434-012-2278-6. Epub 2012 Mar 21. - MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y, Mori M.
Ann Surg Oncol. 2012 Sep;19(9):3065-71. doi: 10.1245/s10434-012-2246-1. Epub 2012 Feb 10. - Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.
Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9. - A new PICTure of nucleolar stress.
Suzuki A, Kogo R, Kawahara K, Sasaki M, Nishio M, Maehama T, Sasaki T, Mimori K, Mori M.
Cancer Sci. 2012 Apr;103(4):632-7. doi: 10.1111/j.1349-7006.2012.02219.x. Epub 2012 Mar 8. Review. - Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases.
Akiyoshi S1, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M.
Br J Cancer. 2012 Oct 9;107(8):1345-53. doi: 10.1038/bjc.2012.326. Epub 2012 Sep 6. - RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma.
Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Nagai Y, Ishimoto T, Baba Y, Mimori K, Baba H.
Br J Cancer. 2012 Oct 9;107(8):1233-8. doi: 10.1038/bjc.2012.396. Epub 2012 Sep 6. - Review: Single nucleotide polymorphisms associated with the oncogenesis of colorectal cancer.
Mimori K, Tanaka F, Shibata K, Mori M.
Surg Today. 2012 Feb;42(3):215-9. doi: 10.1007/s00595-011-0038-z. Epub 2011 Nov 30. Review. - Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Kim HM, Haraguchi N, Ishii H, Ohkuma M, Okano M, Mimori K, Eguchi H, Yamamoto H, Nagano H, Sekimoto M, Doki Y, Mori M.
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S539-48. doi: 10.1245/s10434-011-2040-5. Epub 2011 Aug 31. - Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer.
Kosaka Y, Mimori K, Fukagawa T, Ishikawa K, Etoh T, Katai H, Sano T, Watanabe M, Sasako M, Mori M.
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S430-7. doi: 10.1245/s10434-011-1905-y. Epub 2011 Jul 15. - Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells.
Ohkuma M, Haraguchi N, Ishii H, Mimori K, Tanaka F, Kim HM, Shimomura M, Hirose H, Yanaga K, Mori M.
Ann Surg Oncol. 2012 Apr;19(4):1357-64. doi: 10.1245/s10434-011-1739-7. Epub 2011 Apr 27.